The global nephrostomy devices market size was valued at USD 940.26 million in 2018 and is anticipated to expand at a CAGR of 7.8% from 2019 to 2026. Increasing cases of kidney stone disorder, a rise in demand for minimally invasive surgical procedures, and increased awareness about the product are a few factors driving the market. According to a study published in the National Center for Biotechnology Information (NCBI), urolithiasis affects around 12% of the world population.
Also, around 13% of men and 7% of women develop a kidney stone in their lifetime. Nephrostomy devices help restore the urine flow through the blocked ureters and return the kidney to the normal function.
The increasing popularity of minimally invasive procedures is also driving the market. Moreover, growing cases of lifestyle-related disorders are likely to contribute to the market development. Improving healthcare infrastructure in the emerging economies is also influencing the global market.
Nephrostomy catheters are extensively used for drainage of a blocked urine collecting system. This blockage causes hydronephrosis, which is operated with the help of nephrostomy catheters. Hence, a rise in the number of hydronephroses is expected to impel the demand for catheters, thereby fueling the nephrostomy devices' market growth.
Increasing cases of bladder, ovarian, and prostate cancers are also estimated to have a positive impact on product demand over the forecast years. Furthermore, growing incidences of post-operative infections in patients with a kidney transplant is another key driver.
Guidewires segment is expected to hold the maximum share of the market in the forecast period owing to the less-invasive nature of the product. The growing elderly population and the prevalence of urinary and bladder disorders are expected to increase the demand for the product, thereby influencing the growth of the segment.
The manufacturers of the guidewire are focusing on collaborations with the healthcare practitioners to increase their customer base and strengthen their presence in the industry. Hence, such initiatives by the manufacturers and the presence of well-established and skilled practitioners in the developed economies are expected to increase the demand for guidewires. Technological advancements in nephrostomy devices, such as the introduction of balloon dilation catheter with original multilayer technology, are anticipated to offer lucrative opportunities to the market.
Ambulatory surgical centers (ASCs) are likely to witness the fastest CAGR from 2019 to 2026 as they offer more personalized services. Furthermore, the better outcome of results as compared to hospitals and other healthcare settings is also driving the segment.
Infection risks during surgery in ASCs are half than that of the hospitals, which also helps boost the segment growth. Besides, ASCs ensure that patient receives personalized service with the improved patient experience since they do not have the challenge of treating different types of illnesses and disorders.
However, the hospital segment accounts for the major market share due to the availability of skilled physicians in hospitals and the rise in spending power of consumers. Also, improving healthcare infrastructure in the developing economies and growing adoption of innovative products by physicians are expected to drive the segment.
North America accounted for the largest share in the past. It is expected to witness substantial growth in the future as well due to favorable reimbursement policies, increasing awareness about the product, availability of highly skilled physicians, and the presence of well-established healthcare facilities in the region. Moreover, the quick adoption of technologically advanced medical products is expected to drive the market in the region. Increasing funding by the government for R&D activities in surgical devices and procedures is also positively affecting the regional market growth.
Asia Pacific is expected to grow at the highest CAGR from 2019 to 2026 due to increasing cases of kidney disorders, positive government initiatives, and various programs by NGOs to raise awareness about the product. Moreover, the presence of a large number of key companies in China and India is contributing to market growth. Rapidly expanding medical tourism market in the emerging economies of Asia Pacific is further expected to boost the product demand, thereby augmenting the market growth.
Major companies in the market are Boston Scientific Corp.; Teleflex, Inc.; Cardinal Health; Becton, Dickinson and Company; Cook Medical; B. Braun Melsungen AG; Coloplast Group; Olympus Corp.; Argon Medical; and Uresil LLC. These companies focus more on new product development, technological advancements, and M&A to strengthen their foothold in the global market. For instance, in February 2017, Cook Medical launched Universa along with the two sets of percutaneous urinary drainage. The brand includes foley catheters and ureteral stents in different configurations and sizes to meet the specific preferences and needs of physicians and patients.
The market size value in 2020
USD 1.1 billion
The revenue forecast in 2026
USD 1.71 billion
CAGR of 7.8% from 2019 to 2026
The base year for estimation
2015 - 2017
2019 - 2026
Revenue in USD million and CAGR from 2019 to 2026
Revenue forecast, company share, competitive landscape, growth factors and trends
Product, end-use, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; Germany; U.K.; France; Italy; Spain; China; Japan; India; Australia; South Korea; Brazil; Mexico; Argentine; Colombia; South Africa; Saudi Arabia; UAE
Key companies profiled
Boston Scientific Corp.; Teleflex, Inc.; Cardinal Health; Becton, Dickinson, and Company; Cook Medical; B. Braun Melsungen AG; Coloplast Group; Olympus Corp.; Argon Medical; Uresil LLC.
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For this study, Grand View Research has segmented the global nephrostomy devices market report based on product, end-use, and region:
Product Outlook (Revenue, 2015 - 2026 (USD Million))
End-Use Outlook (Revenue, 2015 - 2026 (USD Million))
Ambulatory Surgical Centers (ASCs)
Regional Outlook (Revenue, 2015 - 2026 (USD Million))
Middle East & Africa
b. The global nephrostomy devices market size was estimated at USD 1.0 billion in 2019 and is expected to reach USD 1.1 billion in 2020.
b. The global nephrostomy devices market is expected to grow at a compound annual growth rate of 7.8% from 2019 to 2026 to reach USD 1.7 billion by 2026.
b. North America dominated the nephrostomy devices market with a share of 33.45% in 2019. This is attributable to favorable reimbursement policies, increasing awareness about the product, availability of highly skilled physicians, and the presence of well-established healthcare facilities in the region.
b. Some of the key players operating in the nephrostomy devices market include Boston Scientific Corp.; Teleflex, Inc.; Cardinal Health; Becton, Dickinson, and Company; Cook Medical; B. Braun Melsungen AG; Coloplast Group; Olympus Corp.; Argon Medical; and Uresil LLC.
b. Key factors that are driving the market growth include increasing incidence of kidney stones, increased adoption of minimally invasive surgical procedures, and technological advancements.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."